Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, and praziquantel against <em>Schistosoma haematobium</em>: randomized,... (Publications)
properties, yet no clinical studies have been performed. METHODS: We conducted a randomized, exploratory open-label trial to assess the efficacy and safety of mefloquine (25 mg/kg), artesunate (3 doses of 4 mg/kg)
Chimney stoves modestly improved indoor air quality measurements compared with traditional open fire stoves: resulty from a small-scale intervention... (Publications)
Nearly half of the world's population depends on biomass fuels to meet domestic energy needs, producing high levels of pollutants responsible for substantial morbidity and mortality. We compare carbon
Innovative tools and OpenHDS for health and demographic surveillance on Rusinga Island, Kenya (Publications)
Island, western Kenya, has deployed an HDSS. By means of computer tablets in combination with Open Data Kit and OpenHDS data collection and management software experiences with time efficiency, cost effectiveness
Open Calls (Page)
https://www.swisstph.ch/fr/research/leading-house-africa/open-calls
Open Calls We are pleased to announce that the State Secretariat for Education, Research and Innovation (SERI) has renewed our Leading House Africa mandate for 2025–2028. We will soon provide updates on
Genotype-Informed Versus Empiric Management Of VirEmia (GIVE MOVE): study protocol of an open-label randomised clinical trial in children and... (Publications)
an unsuppressed viral load (VL) while taking antiretroviral therapy (ART). METHODS: GIVE MOVE is an open-label randomised clinical trial enrolling children and adolescents (> /=6 months to /=400 copies/mL